FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of ...

This optimism is reflected in the stock’s impressive performance, with shares rising by approximately 350% since the initiation of the Phase 1 study in late April. Moreover ... and Japan by 2037, ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

All 26 of Georgia’s public universities and colleges added students this fall in the strongest enrollment surge in years.

1. Current NAV: The Current Net Asset Value of the Edelweiss Equity Savings Fund - Regular Plan as of Nov 13, 2024 is Rs 23.58 for Growth option of its Regular plan. 2. Returns: Its trailing returns ...